chr14-23117491-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_001805.4(CEBPE):c.842G>A(p.Ser281Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000122 in 1,611,224 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001805.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CEBPE | NM_001805.4 | c.842G>A | p.Ser281Asn | missense_variant | 2/2 | ENST00000206513.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CEBPE | ENST00000206513.6 | c.842G>A | p.Ser281Asn | missense_variant | 2/2 | 1 | NM_001805.4 | P1 | |
CEBPE | ENST00000696121.1 | n.811G>A | non_coding_transcript_exon_variant | 3/3 | |||||
CEBPE | ENST00000696122.1 | n.588G>A | non_coding_transcript_exon_variant | 3/3 |
Frequencies
GnomAD3 genomes AF: 0.000716 AC: 109AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000183 AC: 45AN: 246468Hom.: 0 AF XY: 0.000172 AC XY: 23AN XY: 133452
GnomAD4 exome AF: 0.0000583 AC: 85AN: 1458902Hom.: 0 Cov.: 32 AF XY: 0.0000441 AC XY: 32AN XY: 725644
GnomAD4 genome AF: 0.000735 AC: 112AN: 152322Hom.: 0 Cov.: 32 AF XY: 0.000685 AC XY: 51AN XY: 74480
ClinVar
Submissions by phenotype
Specific granule deficiency 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | May 21, 2021 | - - |
CEBPE-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 12, 2023 | The CEBPE c.842G>A variant is predicted to result in the amino acid substitution p.Ser281Asn. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.26% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/14-23586700-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Specific granule deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at